Avalere’s Post

"Drug databases that empower critical decisions." FDB (First Databank, Inc.) delivers highly trusted drug databases designed to support medication decision making, thereby improving patient safety, efficiency, and health outcomes. They compile their databases from authoritative sources, critically reviewed by their clinical team, to turn drug data into actionable drug knowledge. Learn more at https://www.fdbhealth.com/ #DrugKnowledge #MedicationSafety #SoHCSpotlights

Trexin will be hosting a Drug Diversion webinar on Wednesday, September 13th. Registration information is below. Three #Healthcare professionals will provide their perspectives on measuring Drug Diversion program outcomes and more. #Data #DataAnalytics #HealthcareAnalytics #PrescriptionDrugs #DrugDiversion #DrugSafety

A great webinar regarding Drug Diversion programs - be sure to sign-up for this event!! #healthcare #consultingexperts #drugdiversion

This article illustrates an unfortunate part of our healthcare system. It seems to reason that patients should benefit from competition caused by #biosimilars. In the end, patients are often left without benefit and lower list price biosimilar competition can help some patients better afford their medications. We should aspire to have a patient centric system that makes medications more affordable for those who take them while also making it less confusing to navigate. https://lnkd.in/ermANdcR

Medication errors are a leading cause of preventable harm in healthcare, affecting millions of patients and prolonging hospital stays each year. Miscommunication, complex drug regimens, and lack of specialized knowledge can lead to serious, sometimes fatal, consequences. But there's a solution: Pharmacist-led rounds. When pharmacists are an integral part of daily medical rounds, we leverage their expertise in medication management to ensure accurate dosing, prevent adverse drug interactions, and tailor treatment plans. This collaborative approach significantly reduces errors and enhances patient outcomes. Learn more about Pharmacist-led rounds in our latest piece: https://lnkd.in/d4hFQSNY #RemedialHealth #Pharmacist #MedicalRounds #PatientSafety #Healthcare

Don't miss part 2 of our drug diversion prevention webinar series: "Protecting and Supporting your Workforce" on Thursday, November 9th at 2 PM ET. During the webinar, our expert panelists will offer new perspectives on this sensitive issues surrounding the reasons for diversion and how to best educate, support and protect their workforce, with consideration of: 📈 Current trends and impact of drug diversion in healthcare today 👨⚕️👩⚕️Societal changes that impact healthcare workers 🏥 Establishing a culture in which reporting drug diversion is encouraged 💊 Methods to support those that divert to get the help they need When you register, you will also receive the recording of Part 1: "The Impact of an Evolving Healthcare on Drug Diversion" https://bit.ly/495hqDj #DrugDiversion #WebinarSeries #EvolvingHealthcare #DiversionMonitoring #DrugDiversionPrevention

In the first of four extracts from last week's EU, UK, and Asia session of our Global Innovative Contracting webinar, our speakers Adam Meads and Omar Ali shed light on England's newly introduced guidelines for free-of-charge medicine schemes, that aim to prevent distorted geographical prescribing patterns. Omar, with extensive experience in the UK, recalls some companies offering free medicines until NICE evaluations were completed, leading to tensions between clinicians and payers over potential future liabilities... #MarketAccess #LifeSciences #PharmaIndustry #HealthcareInnovation #ValueBasedCare #PricingStrategy #HealthEconomics #GlobalHealthcare

March 14, 2024: Rezdiffra™ was approved by the FDA as the first-ever therapeutic for #MASH. March 29, 2024: The first prescription for Rezdiffra™ was facilitated by Echosens’ FibroScan® technology.   The liver health revolution is here.   Echosens is more than just a part of healthcare, we're at the forefront of innovation and global leadership. Echosens’ noninvasive technology is empowering clinicians to both qualify and monitor patients for Rezdiffra™.   Here's to many more milestones achieved through innovation, dedication, and the relentless pursuit of liver health for all!   #Liverhealthmatters #liverdisease

While cost-sharing can be expressed as a well-intended benefit design, it can negatively affect long-term drug adherence by patients. AMCP supports efforts to reduce out-of-pocket costs where appropriate, including provisions of the Inflation Reduction Act. However, there could be long-term and unintended consequences in reducing premiums, so it is crucial to develop comprehensive and patient-centric solutions to address these issues over time. AMCP, along with our partners, look forward to our continued efforts to address these complex solutions. https://bit.ly/3T6LSFH #drugpricing #healthequity #patientaccess

Confused about covering new-gen weight loss drugs? Should you avoid skyrocketing health spend but ditch coverage? Or watch BMIs do the yo-yo for pre-certification? Hold on tight, there's a game-changer option! Hosted by Quizzify & US Preventive Medicine, this informative webinar will help you decode the new weight loss drugs and how to save money while appealing to your employees. Manage your money wisely and offer the best coverage to your employees! Sign up for the webinar now! We are proud to feature Quizzify on The Granite List. #WebinarWisdom #WeightLossDrugs #TheGraniteList